指南与共识腹部CTMR

克罗恩病「可能狭窄」:支持SAR共识建议

Probable Stricturing in Small Bowel Crohn Disease: In Support of SAR Consensus Recommendations.
指南 / 共识 · AJR Am J Roentgenol · 2026-01-07

本文为AJR述评,聚焦小肠克罗恩病中肠壁增厚伴固定管腔狭窄但无上游扩张的中间阶段。作者依据SAR IBD专家小组共识,主张将其定义为「可能狭窄」,并呼吁纳入影像报告、临床分型与治疗路径。

要点

  • 肠壁增厚伴管腔固定变窄但无上游扩张时,应报告为「可能狭窄」
  • 可能狭窄与明确狭窄(伴上游扩张)在预后和生物学特征上不同
  • Montreal和Paris分型将此类病变归为炎症表型,未能反映狭窄风险

核心结论

  • 「可能狭窄」是克罗恩病中具有独特生物学和临床特征的一个独立影像学阶段,应纳入影像报告、临床分型与治疗路径。
  • 肠壁增厚伴固定管腔狭窄(管腔直径减少>50%)但无上游扩张,符合SAR共识中的可能狭窄定义。

研究设计与样本

  • 本文为AJR perspective文章,非原始研究,基于SAR IBD疾病聚焦小组共识声明进行论证和解读。

关键影像表现/征象

  • 活动性炎症表现为单纯肠壁增厚,无管腔狭窄或上游扩张。
  • 可能狭窄表现为肠壁增厚伴管腔直径减少>50%,但无上游扩张。
  • 明确狭窄表现为肠壁增厚、管腔狭窄伴上游肠管扩张,提示梗阻风险。

诊断标准与关键数值

  • SAR共识:肠壁增厚伴固定管腔狭窄但无上游扩张,应视为可能狭窄。
  • 管腔狭窄定义为肠管直径减少>50%。
  • Montreal和Paris分型将肠壁增厚伴管腔狭窄归为炎症表型而非狭窄表型。

临床应用与阅片要点

  • 影像报告中应明确区分单纯炎症、可能狭窄和明确狭窄三个级别。
  • 对可能狭窄的识别有助于个体化治疗决策,避免漏报潜在狭窄进展风险。
  • 阅片时需注意管腔狭窄的判断应基于固定性狭窄,而非可逆性痉挛。

局限性

  • 本文为观点性文章,未报告原始研究数据、样本量或统计检验结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Crohn disease is a chronic immune-mediated gastrointestinal disorder affecting nearly 1 million people in the United States. Despite therapeutic advances, many patients do not achieve durable intestinal healing, and stricture-related complications, including internal penetrating disease, remain frequent. Disease often progresses radiologically from isolated active inflammation (characterized by bowel wall thickening), to associated luminal narrowing (i.e., > 50% diameter reduction), to associated upstream dilatation (i.e., overt stricture, with obstruction risk). The intermediate stage of wall thickening with luminal narrowing is associated with distinct biomarker profiles, microbial signatures, gene expression patterns, imaging features, and prognostic outcomes. Accordingly, consensus statements from the Society of Abdominal Radiology Inflammatory Bowel Disease Disease-Focused Panel indicate that patients with bowel wall thickening and fixed luminal narrowing without upstream dilatation should be considered to have probable strictures. Yet, current clinical classification systems do not fully incorporate this radiologic entity. For example, the Montreal and Paris classifications have historically classified patients with wall thickening and luminal narrowing as having the inflammatory rather than stricturing phenotype. This Perspective summarizes evidence supporting probable strictures as a distinct biologic and clinical entity that could aid individualized care and argues for integrating probable stricturing into radiology reports, clinical classification schemes, and treatment pathways.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Dillman, Rieder, Baker, et al. Probable Stricturing in Small Bowel Crohn Disease: In Support of SAR Consensus Recommendations. AJR Am J Roentgenol. 2026. PMID: 41499701. doi:10.2214/AJR.25.34245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。